Molecular Specification
| Compound type | Full-length actin-binding peptide (thymosin β4) |
|---|---|
| Amino-acid length | 43 |
| Sequence | Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES |
| Molecular formula | C212H350N56O78S |
| Molecular weight | 4963.4 Da (avg) |
| CAS number | 77591-33-4 |
| Physical form | Lyophilized powder (typically acetate salt) |
| Verification | Third-party HPLC tested; Certificate of Analysis included |
Reference data for research use only. Confirm identity and purity against the batch Certificate of Analysis.
Sources & References
Peer-reviewed research
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Research FAQ
Compound and research-use information
What is Thymosin Beta-4 (TB-500)?
TB-500 is a synthetic peptide fragment related to thymosin beta-4, a naturally occurring actin-binding protein. It is provided for laboratory research use.
What is Thymosin Beta-4 (TB-500) studied for in the research setting?
In research settings TB-500 / thymosin beta-4 is used to study actin regulation, cell migration, and angiogenesis in in vitro and preclinical tissue-repair models. It serves as a reference peptide for cytoskeletal and wound-biology research.
What form is Aurevena's Thymosin Beta-4 (TB-500) supplied in?
Thymosin Beta-4 (TB-500) is supplied as a lyophilized (freeze-dried) powder. Every batch is tested by independent, accredited U.S. laboratories for purity and identity, with the Certificate of Analysis published on this product page. Store lyophilized peptide cold and protected from light, and avoid repeated freeze-thaw cycles.
Is Thymosin Beta-4 (TB-500) intended for human use?
No. Thymosin Beta-4 (TB-500) is sold by Aurevena strictly for laboratory and research use only. It is not a drug, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use, consumption, or for the diagnosis, treatment, cure, or prevention of any disease.




